The plain truth is that good-quality scientific evidence for medical cannabis is still limited for many of the conditions people seek it for. That does not end the conversation. It can be considered with transparency, reliable information and close follow-up, without turning a possibility into a promise.
The question usually comes from patients themselves. It is worth exploring what lies behind it: what has not improved, which treatments caused problems and what you hope to find. Often, that conversation opens other paths that might make sense before or alongside cannabis use.
When evidence is weak, a decision needs greater care. The person’s preference matters, as do the clinical context, available alternatives and the balance of risks and possible benefits. Consent alone does not make every prescription appropriate.
What the evidence allows us to say
Medical cannabis includes products with different compositions. A result found for one product and condition does not automatically apply to another oil or another illness. Doses and responses also vary between people.
There is stronger evidence for a specific CBD formulation in treating seizures associated with certain epilepsies, such as Dravet syndrome, Lennox-Gastaut syndrome and tuberous sclerosis. For chronic pain, some THC-containing products have shown short-term benefit, mainly in studies of neuropathic pain, but also increased dizziness and drowsiness. Important uncertainties remain about long-term use.
For other concerns, such as anxiety, insomnia and fibromyalgia, findings are more preliminary or conflicting. Many patients report meaningful changes in sleep, symptoms and quality of life. Those accounts deserve attention and follow-up, even though they cannot establish that the product will have the same effect for someone else.
With these uncertainties, it makes a difference to have a professional whose clinical knowledge extends beyond cannabis. Care needs to address the problem that brought you to the appointment, other possible treatments and what is happening in your life. It cannot be reduced to prescribing a medicine.
Before prescribing
The assessment includes current medicines and supplements, previous treatments and your health history. It is important to understand interactions, individual risks and alternatives with more established evidence for your situation.
CBD and THC have different effects, and the ratio between them matters. Even CBD products can cause side effects and interactions. Alcohol, drowsiness, driving safety and a possible need to monitor the liver belong in the conversation, depending on the product and your history.
Follow-up is part of prescribing
A trial needs clear goals: what is expected to improve, how to observe that change and when to discuss it again. At follow-up appointments, benefit, unwanted effects and the impact on everyday life help decide whether to continue, adjust or stop treatment.
Responsible prescribing includes acknowledging uncertainty and being available to reconsider the approach. My aim is for that conversation to be honest, without automatic enthusiasm or dismissing from the outset a possibility that could make sense for you.